Seeking Alpha

NERV
  Minerva Neurosciences - NASDAQ

8/22/2014, 9:48 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
NERV vs. ETF Alternatives
Company Description
Minerva Neurosciences Inc is a development stage bio-pharmaceutical company. It develops experimental drugs for the treatment of schizophrenia, insomnia and Parkinson's disease.
Sector: Healthcare
Industry: Biotechnology
Country: United States